CPT1C and cancer: Currently, the majority of studies have demonstrated that despite CPT1C exhibiting suboptimal catalytic activity and being situated within the endoplasmic reticulum, it still affects the malignant biological learning of cancer cells by altering downstream FAO rates [103].